8-K//Current report
Ambrx Biopharma Inc. 8-K
Accession 0000950170-23-044643
CIK 0001836056operating
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 5:23 PM ET
Size
236.6 KB
Accession
0000950170-23-044643
Documents
- 8-Kamam-20230825.htmPrimary
8-K
- EX-101.DEFamam-20230825_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
- EX-101.LABamam-20230825_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.SCHamam-20230825.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.PREamam-20230825_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLamam-20230825_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-23-044643-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ambrx Biopharma Cayman, Inc.
CIK 0001836056
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001836056
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 5:23 PM ET
- Size
- 236.6 KB